Khaitan, CAM, Troutman Sanders, Simpson Thacher on Fosun’s acquisition of Gland Pharma for $1.26 billionJuly 29 2016
Shanghai Fosun Pharmaceutical, a leading Chinese health care provider, has signed an agreement to buy an 86 per cent stake in Hyderabad-based Gland Pharma for $1.26 billion (Rs.8,500 crore).
This is the largest acquisition of an Indian company by a Chinese firm and the biggest inbound M&A so far this year, reported ET.This content is restricted to subscribers
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports